Medical Oncology, Radiation Oncology And Nuclear Medicine

Medical Oncology

The services include an oncology daycare and inpatient ward. The department provides screening, diagnosis and treatment for cancers affecting the digestive and other systems. Evidence-based chemotherapy protocols as per the standard guidelines are followed. Chemotherapy is administered with supportive treatment and a tender loving nursing care. Provisions for PICC line and chemoport insertion are available. Targeted molecular therapy and immunotherapy is practiced as per scientific evidence. Precision medicine is an evolving area in cancer treatment with potential for minimal side-effects. Individualised cancer treatment based on the patient-specific tumor markers, receptor testing, mutation testing, and/or next generation sequencing is recommended. Our team is well experienced and has a special expertise in managing all gastrointestinal malignancies, head and neck cancers, breast cancers and all adult and pediatric solid tumors and hematological disorders.

Radiation Oncology

A state-of-the-art linear accelerator (Versa HDTM) is utilized for evidence-based treatment of cancers with external radiotherapy with energy of 6 MV, 10 MV, 15 MV X-rays, and electron therapy. The linear accelerator machine is equipped for KV, MV, and CBCT image guidance. The department is well-equipped with mould room, 4-D CT simulator, and computerized treatment planning system. Provisions for advanced radiation technologies like IGRT, SBRT, SRS/SRT, VMAT, IMRT, and 3-DCRT for all cancers are available. Advanced treatment with SBRT for hepatopancreaticobiliary cancers is a special area of expertise at ILBS. Motion management with respiratory gating is available for precise targeting of tumors. There is provision for 4-D CT for defining tumor motion along the breathing cycle. Focused and conformal radiation delivery to tumor target with sparing of normal tissues is the intent of radiotherapy for providing best outcome and quality of life to patients with cancer. Our team of well trained and experienced oncologists, physicists, and technologists work together for providing best care to patients. Our team has treated a considerable number of patients with radiation therapy for liver cancer and/or portal vein tumor thrombus and has developed skills required in this challenging field. Our results show 1-year 80-90% local control rate in the targeted liver tumors (Hepatocellular carcinoma) treated with radiation therapy. The department is involved in providing specialized training in advanced technologies especially for HPB and GI malignancies.

Nuclear Medicine

With advancements in technology and research, management of various cancers are being increasingly directed at the molecular and cellular levels in the form of targeted therapies. The assessment of disease status and response rates are increasingly being relied upon functional and metabolic signatures over and above the morphological changes. The need for a more precise diagnosis, prognostication of diseases and personalized medicine has moved the entire world like never seen before and ILBS is no exception. ILBS is running dedicated nuclear medicine facilities with a state-of-the-art 128-slice time-offlight PET-CT. The uniqueness of PET-CT lies on its ability to non-invasively assess diseases at the metabolic and molecular levels. Our team has gained special expertise in defining utility and interpretation of PET-CECT in hepatopancreatobiliary and gastrointestinal malignancies. The PET-CT machine is configured and utilized for the purpose of radiation planning CT and/or 4-DCT. We recently initiated Y-90 transarterial radioembolization (TARE) using a scout-dose, PET-CT-based planning workflow. This approach enables individualized, voxel-level dosimetry and improves confidence in target coverage while monitoring non-target liver dose. The program strengthens our theranostics services and supports safer, precision delivery of TARE in eligible patients. The institute is looking forward to procuring a 16- slice state-of-the-art SPECT-CT machine and establishing nuclear medicine therapy ward for Peptide Receptor Radionuclide Therapy (PRRT) and other high dose nuclear medicine therapies.

Indications of PET - CT:

Services Rendered

New services & facilities

• Irradiation of blood products
• TARE

Educational Activities

• a. Details of the Educational activities (CME/Conf/workshop/webinars) hosted by the department in 2025:
  • 1. Tumor Board meeting, journal club, and grand rounds held on a regular basis
  • 2. Organized a Programme with guest lectures and meeting with cancer survivors on the World Cancer Day at ILBS on 04 February 2025
  • 3. Dr. Puja Sahai, Dr. Deepti Sharma, and Dr. Mangu Srinivas Bharadwaj completed the NMC approved Basic Course in Medical Education in 2025 at MAMC, New Delhi
• b. Courses offered

  Course	No. of seats
  Post Doctoral Certificate Course in HPB and GI Advanced Radiation Oncology	3
  Post Doctoral Certificate Course in GI Medical Oncology	3

Departmental Achievements in 2025

Research activities in the Department:

• 1. ILBS is participating in multicentric project - 'Hospital Based Cancer Registries in India' under National Cancer Registry Programme through ICMR-NCDIR from 2017 onwards
• 2. Radiation Oncology team - Dr. Hanuman Prasad Yadav, Dr. Puja Sahai, Dr. Deepti Sharma participated in the conferences organized by ILBS - DRILLS, Hot Topics at AASLD 2025 at New Delhi
• 3. Radiation Oncology team participated in the INASL-ILCA School of Liver Cancer 2025 meeting at Gurugram
• 4. Dr. Puja Sahai presented poster at the Asia-Pacific Gastroenterology Cancer Summit 2025 at Singapore
• 5. Dr. Deepti Sharma presented poster at the AROICON 2025 at Kolkata and the EASL 2025
• 6. Dr. Deepti Sharma participated in INASL 2025 at Chandigarh, OFCON 2025, NE AROICON 2025 at Arunachal Pradesh, and LTSICON 2025 at New Delhi
• 7. Dr. Mangu Srinivas Bharadwaj participated in the Northern Chapter Annual Conference of Society of Nuclear Medicine India 2025 at New Delhi, ANMPICON 2025 at Hyderabad, and Nuclear medicine therapy update 2025 at Hyderabad
• 8. Dr. Jasim Jaleel participated in the SPEEDCON 2025 at New Delhi, Northern Chapter Annual Conference of Society of Nuclear Medicine India 2025 at New Delhi, and the Asia-Oceania Conference of Nuclear Medicine and Molecular Biology 2025 at Chennai

Visiting faculty to the department in 2025

Data from Hospital Based Cancer Registry of ILBS under National Cancer Registry Programme through ICMR-NCDIR